REG - Abbott Laboratories - Announcement of Intention to Delist <Origin Href="QuoteRef">ABT.N</Origin>
RNS Number : 4746KAbbott Laboratories21 September 2016
Company
Abbott Laboratories
TIDM
ABT
Headline
Statement re: Intention to Cancel Listing
21 September 2016
INTENTION TO CANCEL LISTING OF SHARES
Abbott Laboratories hereby announces that it has applied for the cancellation of the listing of its common shares without par value on the Official List, which will result in the cancellation of the trading of its common shares on the London Stock Exchange, to take effect on 21 October 2016.
This notice is given in fulfilment of the obligation under LR 5.2.8.
Enquiries:
Abbott Financial:
Scott Leinenweber, Vice President, Investor Relations, +1-224-668-0791
Abbott Media:
Scott Stoffel, Divisional Vice President, External Communications, +1-224-668-5201
This information is provided by RNSThe company news service from the London Stock ExchangeENDSTRLLFEVASILFIR
Recent news on Abbott Laboratories
See all newsABBOTT LABORATORIES INVESTIGATION REMINDER ALERT: Scott+Scott Attorneys at Law LLP Continues to Investigate Abbott Laboratories’ Directors and Officers for Breach of Fiduciary Duties – ABT
NewsNYSE ORDER IMBALANCE <Origin Href="QuoteRef">ABT.N</Origin> 66480.0 SHARES ON SELL SIDE
NewsUPDATE 1-Baby formula supplies improving, say U.S. retailers Walmart and Target
NewsNYSE ORDER IMBALANCE <Origin Href="QuoteRef">ABT.N</Origin> 63921.0 SHARES ON BUY SIDE
NewsWalmart says baby formula availability improving in its stores
News